Skorstengaard 2014.
| Methods | Patients from oncology, cardiology, and respiratory departments Country: Denmark Age: not reported Sex: not reported Inclusion criteria: patients from oncology, cardiology, and respiratory departments Exclusion criteria: not reported N randomised: not reported N in analysis: not reported |
| Participants |
Content of screen: well‐being and preferences for end‐of‐life care Interventionist: a healthcare professional conducts the discussion with the participant and if possible a relative Intervention procedure: unclear Conditions for implementation: not reported Comparative condition: usual care Length of follow‐up: unclear |
| Interventions |
Primary outcomes/Secondary outcomes
Outcome time points: unclear, relatives are questioned after participant death |
| Outcomes | Information from conference abstract available, no further information received from study authors |
| Notes |
Abbreviations:
ADL: Activities of Daily Living BPI: Brief Pain Inventory CFS: Chronic Fatique Symptoms CG: control group DT: Distress Thermometer EORTC QLQ‐BR23: European Organisation for Research and Treatment of Cancer‐Quality of Life Questionnaire‐Breast Cancer 23 items EORTC QLQ‐C30: European Organisation for Research and Treatment of Cancer‐Quality of Life Questionnaire‐Core 30 items EORTC QLQ‐HN35: European Organisation for Research and Treatment of Cancer‐Quality of Life Questionnaire‐Head and Neck Cancer 35 items ePROM: electronic patient reported outcome measures ESAS‐r: Edmonton Symptom Assessment System‐revised FACIT‐II: Functional Assessment of Chronic Illness Therapy version 2 FACT‐HN: Functional Assessment of Cancer Therapy‐Head and Neck Cancer GAD‐7: Generalized Anxiety Disorder 7‐item scale HADS: Hospital Anxiety and Depression Scale HRQoL: health‐related quality of life IG: intervention group iPEHOC: Improving Patient Experience and Health Outcomes Collaborative MDT: multidisciplinary team PHQ‐9: Patient Health Questionnaire 9‐item depression module POMS: Profile of Mood States RCT: randomised controlled trial VES‐13: Vulnerable Elders Survey.